According to the report published by the Market Research Store, global demand for the Acute Pancreatitis Treatment market was estimated at approximately USD 5,018.3 Million in 2020 and is anticipated to generate revenue of around USD 7,081.7 Million by end of 2026, growing at a CAGR of around 6.23% between 2021 and 2026.
Global Acute Pancreatitis Treatment Market: Overview
The term acute pancreatitis is a sudden inflammation in the pancreas due to numerous causes in the body together with gallstone, systemic disease, and use of heavy alcohol. Generally, gallstones produces about 40% of cases of acute pancreatitis. With the help of short-term hospitalization treatment, mild acute pancreatitis can be treated. In case of severe acute pancreatitis, patients need hospitalization for a longer period of time where they are likely to give intravenous fluids or admitted to the ICU for additional treatment.
| REPORT SNAPSHOT & REPORTING DATA TIMEFRAME | |
|---|---|
| Parameter | Details |
| Historical Date ( Actual Data) | 2016 - 2020 |
| Base Year Data | 2020 |
| Current Year Data | 2021 |
| Projected Data | 2021 - 2026 |
Global Acute Pancreatitis Treatment Market: Growth Factors
Due to the Increase in cases of obesity and gallstones the occurrence of acute pancreatitis patient is rising across the world. According to WHO, 39% of adults aged 18 years and above were overweight in 2016. Overall, about 13% of the world's adult population (15% of women and 11% of men) was obese in 2016. The incidence of obesity nearly tripled between 1975 and 2016 across the world. Prevalence of acute pancreatitis was reported from 17 countries across Europe and ranged from 4.6 to 100 per 100 000 population. Prevalence was usually elevated in eastern or northern Europe. Currently, acute pancreatitis is a highly common cause for hospitalization of a gastrointestinal related disease in the U.S. Presently, acute pancreatitis is a specifically usual cause for the hospitalization of a gastrointestinal related disease. Moreover, increasing awareness and advancements of essential devices and instruments is another factor stimulating the market growth. Also, increasing investment in healthcare sector will boost the market.
However, poor recovering policies for the treatment of this disorder may hinder the market growth.
Global Acute Pancreatitis Treatment Market: Segmentation
On the basis of type, the global acute pancreatitis treatment market is segmented into drug therapy, device based therapy and others. The drug-based therapy segment can be further divided into antibiotics, analgesics, and others and the device based therapy can be segmented into endoscopic retrograde cholangiopancreatography (ERCP), intravenous fluid, and surgery. The others segment can be segregated into antioxidant therapy, nutritional support, and others.
Further the market for acute pancreatitis treatment, the end user industry is classified into hospitals, antioxidant therapy and others.
Global Acute Pancreatitis Treatment Market: Regional Analysis
North America is dominating the acute pancreatitis treatment in terms of revenue followed by Europe. The reported yearly prevalence of acute pancreatitis in the U.S. ranges from 4.9 to 35 per 100,000 population. Moreover, the market in Asia Pacific is expected to grow at crucial CAGR during the forecast period. Furthermore, the increasing investment in healthcare sector in specific region enhances the market. In Japan, the approximated number of patients with AP showed a 1.8-fold growth in the last decade. In 2015, according to a survey published in NCBI, the incidences in Japan was 49.4 per 100,000 population.
Global Acute Pancreatitis Treatment Market: Competitive Players
Major key industries in global acute pancreatitis treatment market include, Samsung Bioepis, AstraZeneca, Pfizer, GNT Pharma, CalciMedica, B. Braun Melsungen, General Electric Company, Abbott Pharmaceutical, Fresenius Kabi USA, Sun BioPharma, GlaxoSmithKline, Novartis, Boston Scientific Corporation, SCM Lifescience, and Medtronic.
Global Acute Pancreatitis Treatment Market: By Type
Global Acute Pancreatitis Treatment Market: By End User
Global Acute Pancreatitis Treatment Market: Regional Segmentation Analysis
Frequently Asked Questions
What are the key factors driving global acute pancreatitis treatment market expansion?
Due to the Increase in cases of obesity and gallstones the occurrence of acute pancreatitis patient is rising across the world. Presently, acute pancreatitis is a specifically usual cause for the hospitalization of a gastrointestinal related disease. Moreover, increasing awareness and advancements of essential devices and instruments is another factor stimulating the market growth. Also, increasing investment in healthcare sector will boost the market.
What will be the value of global acute pancreatitis treatment market during 2020- 2026?
The acute pancreatitis treatment is expected to grow at a significant CAGR during the forecast period due to the essential products and the increase in investment of pharmaceutical companies.
Which region will make notable contributions towards global acute pancreatitis treatment market revenue?
North America is dominating the acute pancreatitis treatment in terms of revenue followed by Europe. Moreover, the market in Asia Pacific is expected to grow at crucial CAGR during the forecast period.
What are the key players leveraging global acute pancreatitis treatment market growth?
Major key industries in global acute pancreatitis treatment market include CalciMedica, SCM Lifescience, Samsung Bioepis, GNT Pharma Co, AstraZeneca, B. Braun Melsungen AG, General Electric Company, Medtronic, Abbott Laboratories, Sun BioPharma, Inc, Boston Scientific Corporation, Fresenius Kabi USA, GlaxoSmithKline, Novartis AG, and Pfizer.
Acute Pancreatitis Treatment
Acute Pancreatitis Treatment
×